Skip to search formSkip to main contentSkip to account menu

CY 1503

Known as: CY-1503 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

OligosaccharidesSLeX-OS

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Sialyl LewisX oligosaccharide preserves myocardial and endothelial function during cardioplegic ischemia.
1999
1999
Effect of sialyl Lewis(x) oligosaccharide on myocardial and cerebral injury in the pig.
1999
1999
The sialyl Lewis X analogue, CY-1503, down-regulates leucocyte-endothelium interactions and the inflammatory response.
OBJECTIVE To elucidate mechanisms of protection of ischaemic liver with the sialyl Lewis X analogue CY-1503 by regulation of… 
1997
1997
Carbohydrate selectin inhibitor CY-1503 reduces neutrophil migration and reperfusion injury in canine pulmonary allografts.
BACKGROUND Neutrophil adhesion is initiated by the interaction of rapidly expressed endothelial selectins with oligosaccharide… 
1997
1997
Protective role of synthetic sialylated oligosaccharide in sepsis-induced acute lung injury.
Proper engagement of leukocyte and endothelial cell selectins with their counterreceptors is an initial step in neutrophil… 
1996
1996
Role of sialyl Lewis(x) in total hepatic ischemia and reperfusion.
BACKGROUND Neutrophil adhesion and migration is associated with hepatic ischemia and reperfusion. The role of a Sialyl Lewis(x… 
1995
1995
New agents in development to tackle myocardial ischaemia
&Researchers are studying a variety of approaches to limit ischaemic damage in patients with MI. Contending agents include CY… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)